EUVIMEDEUVIMED entdecken
Crossref

Risk Factors for Peritonitis in Patients With Systemic Lupus Erythematosus Undergoing Peritoneal Dialysis

Ping Hsuan Kuo iD, Yi-Syuan Sun iD, Pu-Jun Fang iD, Szu-Yuan Li iD, Chien-Chih Lai iD

International Journal of Rheumatic Diseases · 2026-03 · 29 (3)

DOI: 10.1111/1756-185x.70597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 09.03.2026. Verfasst von Ping Hsuan Kuo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Immunology, and Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Peritonitis, Lupus Erythematosus, Systemic, Peritoneal Dialysis, Kidney Failure, Chronic. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Taipei Veterans General Hospital, Yen Tjing Ling Medical Foundation, UCB Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Limited evidence exists regarding medication regimens for infection‐prone patients with systemic lupus erythematosus (SLE) undergoing peritoneal dialysis (PD). This study evaluated the association between medication use and peritonitis in patients with SLE on PD and compared peritonitis rates between patients with and without SLE.

Methods

We retrospectively studied patients who underwent PD between 2007 and 2023. Using propensity score matching, we compared 46 patients with SLE and 46 non‐SLE controls matched by sex, date of PD initiation, diabetes mellitus, and age at PD initiation. Peritonitis incidence and risk ratios were calculated using Poisson regression. Time‐dependent Cox proportional hazards model identified risk factors for peritonitis.

Results

Incidence of peritonitis was higher in patients with SLE at 0.32 episodes per patient‐year compared with 0.25 in the controls (risk ratio 1.30, p = 0.15). Time to first peritonitis episode, peritonitis‐associated catheter removal, and mortality rates were similar between the groups. Independent risk factors for peritonitis included male sex (hazard ratio [HR]: 2.29, 95% confidence interval [CI]: 1.22–4.27, p = 0.009), gastric acid suppressants (GAS, HR: 8.71, 95% CI: 2.53–30.05, p < 0.001), and glucocorticoid (GC, HR: 1.16, 95% CI: 1.08–1.26, p < 0.001) in patients with SLE on PD. A significant number of peritonitis was still observed in patients not receiving GC.

Conclusion

PD is a safe dialysis modality for patients with SLE, with comparable outcomes to non‐SLE controls. Nevertheless, the risk of peritonitis in patients with SLE undergoing PD may be increased by the administration of GAS and GC, as well as male sex.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeritonitisLupus Erythematosus, SystemicPeritoneal DialysisKidney Failure, ChronicHumansMaleFemaleRisk FactorsRetrospective StudiesAdultIncidenceMiddle AgedGlucocorticoidsRisk AssessmentTime Factors

Stichwörter der Autor:innen

gastric acid suppressantglucocorticoidperitoneal dialysisperitonitissystemic lupus erythematosus

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • Division of Allergy, Immunology, and Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Division of Allergy, Immunology, and Rheumatology, Department of Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
  • Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

ORCID-Profile: Ping Hsuan Kuo, Yi-Syuan Sun, Pu-Jun Fang, Szu-Yuan Li, Chien-Chih Lai

Förderung

  • Taipei Veterans General Hospital
  • Yen Tjing Ling Medical Foundation
  • UCB Pharma
  • Teh-Tzer Study Group for Human Medical Research Foundation

Zitieren

APA

Kuo, P. H., Sun, Y. S., Fang, P. J., Li, S. Y., & Lai, C. C. (2026). Risk Factors for Peritonitis in Patients With Systemic Lupus Erythematosus Undergoing Peritoneal Dialysis. International Journal of Rheumatic Diseases, 29(3). https://doi.org/10.1111/1756-185x.70597

Vancouver

Kuo PH, Sun YS, Fang PJ, Li SY, Lai CC. Risk Factors for Peritonitis in Patients With Systemic Lupus Erythematosus Undergoing Peritoneal Dialysis. International Journal of Rheumatic Diseases. 2026;29(3). doi:10.1111/1756-185x.70597

BibTeX
@article{Kuo2026,
  author = {Kuo, Ping Hsuan and Sun, Yi-Syuan and Fang, Pu-Jun and Li, Szu-Yuan and Lai, Chien-Chih},
  title = {Risk Factors for Peritonitis in Patients With Systemic Lupus Erythematosus Undergoing Peritoneal Dialysis},
  journal = {International Journal of Rheumatic Diseases},
  year = {2026},
  volume = {29},
  number = {3},
  doi = {10.1111/1756-185x.70597}
}
Kostenlos starten →